Ujházy E, Zeljenková D, Durisová M, Konceková Z, Micek J
Centre of Physiological Sciences, Slovak Academy of Sciences, Bratislava, Czechoslovakia.
Anat Anz. 1988;167(2):113-7.
The pyridoindole derivative (DH 1011), a new antiarrhythmic agent, and quinidine were examined for teratogenic and embryotoxic activity in chick embryos. The tested substance was injected into egg albumen on incubation days 5, 6 or 7 in doses of 0.4, 0.8 or 1.6 mg per egg. All embryos were examined on day 19. A significantly decreased survival rate of embryos was recorded only after the dose of 1.6 mg DH 1011 per egg administered on incubation day 5. Correlation between body and heart weight was found in all surviving embryos after administration of each agent on incubation days 5 and 6. Chondrodystrophy was the major deformity in chick embryos treated on incubation day 5. The results of this investigation suggest that neither quinidine nor DH 1011 have adverse effects on the late embryonal development of chickens.
新型抗心律失常药物吡啶并吲哚衍生物(DH 1011)和奎尼丁在鸡胚中进行了致畸和胚胎毒性活性检测。在孵化第5、6或7天,将受试物质以每枚鸡蛋0.4、0.8或1.6毫克的剂量注入蛋清中。所有胚胎在第19天进行检查。仅在孵化第5天给予每枚鸡蛋1.6毫克DH 1011的剂量后,胚胎存活率显著降低。在孵化第5天和第6天给予每种药物后,在所有存活胚胎中均发现体重与心脏重量之间存在相关性。软骨发育不良是在孵化第5天处理的鸡胚中的主要畸形。本研究结果表明,奎尼丁和DH 1011对鸡胚胎后期发育均无不良影响。